107 related articles for article (PubMed ID: 5013393)
21. Determination of peritoneal phosphate transport as a tool for controlling serum phosphorus.
López-Guerra EA; Rodríguez-García VH; Rodríguez-Castellanos FE
Nefrologia; 2014; 34(5):584-90. PubMed ID: 25259813
[TBL] [Abstract][Full Text] [Related]
22. Systems of membranes involved in peritoneal dialysis.
Rubin J; Jones Q; Planch A; Stanek K
J Lab Clin Med; 1987 Oct; 110(4):448-53. PubMed ID: 3655524
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
[TBL] [Abstract][Full Text] [Related]
24. Acceleration of peritoneal dialysis with minimal N-myristyl-beta-aminopropionate.
el-Bassiouni EA; Mattocks AM
J Pharm Sci; 1973 Aug; 62(8):1314-7. PubMed ID: 4725176
[No Abstract] [Full Text] [Related]
25. Augmentation of peritoneal mass transport by dopamine: comparison with norepinephrine and evaluation of pharmacologic mechanisms.
Hirszel P; Lasrich M; Maher JF
J Lab Clin Med; 1979 Nov; 94(5):747-54. PubMed ID: 501201
[TBL] [Abstract][Full Text] [Related]
26. [Clinical trials of treatment of chronic constipation with a surface-active and hydrotropic agent in oral administration (dioctyl sodium sulfosuccinate with danthron). 64 cases, 41 of these assembled in a table].
Dissard MP
Lyon Med; 1968 Jun; 219(26):2127-42. PubMed ID: 5742457
[No Abstract] [Full Text] [Related]
27. Sorbent based regenerating delivery system for use in peritoneal dialysis.
Lewin AJ; Greenbaum MA; Gordon A; Maxwell MH
Trans Am Soc Artif Intern Organs; 1974; 20A():130-3. PubMed ID: 4450330
[No Abstract] [Full Text] [Related]
28. Constipation in elderly patients; treatment with dioctyl sodium sulfosuccinate and dioctyl sodium sulfosuccinate plus peristim.
SMIGEL JO; LOWE KJ; HOSP PH; GIBSON JH
Med Times; 1958 Dec; 86(12):1521-6. PubMed ID: 13612504
[No Abstract] [Full Text] [Related]
29. Effect of tris(hydroxymethyl)aminomethane on removal of urea by peritoneal dialysis.
McLean WM; Poland DM; Cohon MS; Penzotti SC; Mattocks AM
J Pharm Sci; 1967 Dec; 56(12):1614-21. PubMed ID: 5588714
[No Abstract] [Full Text] [Related]
30. Anti-Candida activity of clotrimazole in combination with dioctyl sodium sulfosuccinate and other surfactants.
Iwata K; Yamaguchi H
Antimicrob Agents Chemother; 1977 Aug; 12(2):206-12. PubMed ID: 332072
[TBL] [Abstract][Full Text] [Related]
31. Cathartics and the sodium pump.
Phillips RA; Love AH; Mitchell TG; Neptune EM
Nature; 1965 Jun; 206(991):1367-8. PubMed ID: 5838253
[No Abstract] [Full Text] [Related]
32. Effect of ultrafiltration on peritoneal dialysis drug clearances.
Lau AH; Chow-Tung E; Assadi FK; Fornell L; John E
Pharmacology; 1985; 31(5):284-8. PubMed ID: 4070353
[TBL] [Abstract][Full Text] [Related]
33. Peristalticstimulating and fecal-hydrating properties of dioctyl sodium sulfosuccinate, danthron, and cascara extracts in the mouse and rat.
LISH PM; DUNGAN KW
J Am Pharm Assoc Am Pharm Assoc; 1958 May; 47(5):371-5. PubMed ID: 13538832
[No Abstract] [Full Text] [Related]
34. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
Grzegorzewska A
Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chronic functional constipation with dioctyl sodium sulfosuccinate and danthron.
BRUSCH CA
J Indiana State Med Assoc; 1959 Oct; 52():1775-8. PubMed ID: 13805405
[No Abstract] [Full Text] [Related]
36. Peritoneal dialysis adequacy: not just small-solute clearance.
Yalavarthy R; Teitelbaum I
Adv Perit Dial; 2008; 24():99-103. PubMed ID: 18986011
[TBL] [Abstract][Full Text] [Related]
37. An experimental model for study of pharmacologic and hormonal influences on peritoneal dialysis.
Maher JF; Hirszel P; Lasrich M
Contrib Nephrol; 1979; 17():131-8. PubMed ID: 487825
[No Abstract] [Full Text] [Related]
38. [The effect of pharmacologic agents on transperitoneal elimination of low-molecular compounds during peritoneal dialysis].
Grzegorzewska A
Pol Arch Med Wewn; 1989; 82(2-3):65-70. PubMed ID: 2638739
[No Abstract] [Full Text] [Related]
39. Dioctyl sodium sulfosuccinate (doxinate) as an adjunct in the roentgenologic investigation of the gastrointestinal tract; a clinical study.
WILSON AK
Am J Roentgenol Radium Ther Nucl Med; 1958 Jul; 80(1):89-94. PubMed ID: 13545467
[No Abstract] [Full Text] [Related]
40. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
